North America Transdermal Patches Market Size, Share & Industry Trends Analysis Report By End User, By Distribution Channel, By Adhesive Type (Acrylic Adhesives, Silicone Adhesives, Hydrogel Adhesives and Others), By Patch Type, By Country and Growth Fore

North America Transdermal Patches Market Size, Share & Industry Trends Analysis Report By End User, By Distribution Channel, By Adhesive Type (Acrylic Adhesives, Silicone Adhesives, Hydrogel Adhesives and Others), By Patch Type, By Country and Growth Forecast, 2023 - 2030


The North America Transdermal Patches Market would witness market growth of 3.9% CAGR during the forecast period (2023-2030). In the year 2019, the North America market's volume surged to 10,98,722.8 thousand units, showcasing a growth of 3.6% (2019-2022).

The market has witnessed remarkable growth and innovation in recent years, reshaping the landscape of pharmaceutical drug delivery. This market, driven by patient convenience, sustained drug release, and improved therapeutic outcomes, has become a pivotal component of the healthcare sector. Adopting transdermal patches has steadily risen across various healthcare domains, driven by several factors contributing to their attractiveness to healthcare providers and patients.

The aging population has also played a significant role in adopting transdermal patches. As the prevalence of chronic diseases rises among the elderly, there is a growing demand for therapeutic options that are not only effective but also user-friendly. These offer a solution to these demographic challenges by providing a convenient and patient-friendly method of drug administration. In addition to the ease of use, these provide controlled and sustained drug release, improving patient compliance and therapeutic outcomes.

North America is witnessing a significant increase in the incidence of chronic diseases such as diabetes, cardiovascular diseases, and chronic pain conditions. The aging population, sedentary lifestyles, and dietary patterns contribute to the higher prevalence of these conditions. Cardiovascular diseases, including hypertension and angina, are prevalent in North America. Therefore, growing chronic disease prevalence in North America is expected to help expand the regional market.

The US market dominated the North America Transdermal Patches Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $2,134.9 million by 2030. The Canada market is experiencing a CAGR of 6.2% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 5.3% during (2023 - 2030).

Based on End User, the market is segmented into Homecare Settings and Hospitals & Clinics. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Based on Adhesive Type, the market is segmented into Acrylic Adhesives, Silicone Adhesives, Hydrogel Adhesives and Others. Based on Patch Type, the market is segmented into Drug-In-Adhesive, Matrix Patches, Reservoir Membrane Patches, Microneedle Patches, Iontophoresis Patches and Vapour Patches. Based on Application, the market is segmented into Pain Management, Smoking Cessation, Hormone Replacement Therapy, Cardiovascular Disorder, Central Nervous System Disorder and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, Viatris, Inc. (Mylan N.V.), Boehringer Ingelheim International GmbH, Endo International PLC, Bayer AG, Nitto Denko Corporation, Cipla Limited, Amneal Pharmaceuticals, Inc., Novartis AG, and AbbVie, Inc.

Scope of the Study

Market Segments covered in the Report:

By End User (Volume, Thousand Units, USD Billion, 2019-2030)
  • Homecare Settings
  • Hospitals & Clinics
By Distribution Channel (Volume, Thousand Units, USD Billion, 2019-2030)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
By Adhesive Type (Volume, Thousand Units, USD Billion, 2019-2030)
  • Acrylic Adhesives
  • Silicone Adhesives
  • Hydrogel Adhesives
  • Others
By Patch Type (Volume, Thousand Units, USD Billion, 2019-2030)
  • Drug-In-Adhesive
  • Matrix Patches
  • Reservoir Membrane Patches
  • Microneedle Patches
  • Iontophoresis Patches
  • Vapour Patches
By Application (Volume, Thousand Units, USD Billion, 2019-2030)
  • Pain Management
  • Smoking Cessation
  • Hormone Replacement Therapy
  • Cardiovascular Disorder
  • Central Nervous System Disorder
  • Others
By Country (Volume, Thousand Units, USD Billion, 2019-2030)
  • US
  • Canada
  • Mexico
  • Rest of North America
Companies Profiled
  • Johnson & Johnson
  • Viatris, Inc. (Mylan N.V.)
  • Boehringer Ingelheim International GmbH
  • Endo International PLC
  • Bayer AG
  • Nitto Denko Corporation
  • Cipla Limited
  • Amneal Pharmaceuticals, Inc.
  • Novartis AG
  • AbbVie, Inc.
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Transdermal Patches Market, by End User
1.4.2 North America Transdermal Patches Market, by Distribution Channel
1.4.3 North America Transdermal Patches Market, by Adhesive Type
1.4.4 North America Transdermal Patches Market, by Patch Type
1.4.5 North America Transdermal Patches Market, by Application
1.4.6 North America Transdermal Patches Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis – Global
4.1 Market Share Analysis, 2022
4.2 Porter’s Five Forces Analysis
Chapter 5. North America Transdermal Patches Market by End User
5.1 North America Homecare Settings Market by Region
5.2 North America Hospitals & Clinics Market by Region
Chapter 6. North America Transdermal Patches Market by Distribution Channel
6.1 North America Hospital Pharmacies Market by Country
6.2 North America Retail Pharmacies Market by Country
6.3 North America Online Pharmacies Market by Country
Chapter 7. North America Transdermal Patches Market by Adhesive Type
7.1 North America Acrylic Adhesives Market by Country
7.2 North America Silicone Adhesives Market by Country
7.3 North America Hydrogel Adhesives Market by Country
7.4 North America Others Market by Country
Chapter 8. North America Transdermal Patches Market by Patch Type
8.1 North America Drug-In-Adhesive Market by Country
8.2 North America Matrix Patches Market by Country
8.3 North America Reservoir Membrane Patches Market by Country
8.4 North America Microneedle Patches Market by Country
8.5 North America Iontophoresis Patches Market by Country
8.6 North America Vapour Patches Market by Country
Chapter 9. North America Transdermal Patches Market by Application
9.1 North America Pain Management Market by Country
9.2 North America Smoking Cessation Market by Country
9.3 North America Hormone Replacement Therapy Market by Country
9.4 North America Cardiovascular Disorder Market by Country
9.5 North America Central Nervous System Disorder Market by Country
9.6 North America Others Market by Country
Chapter 10. North America Transdermal Patches Market by Country
10.1 US Transdermal Patches Market
10.1.1 US Transdermal Patches Market by End User
10.1.2 US Transdermal Patches Market by Distribution Channel
10.1.3 US Transdermal Patches Market by Adhesive Type
10.1.4 US Transdermal Patches Market by Patch Type
10.1.5 US Transdermal Patches Market by Application
10.2 Canada Transdermal Patches Market
10.2.1 Canada Transdermal Patches Market by End User
10.2.2 Canada Transdermal Patches Market by Distribution Channel
10.2.3 Canada Transdermal Patches Market by Adhesive Type
10.2.4 Canada Transdermal Patches Market by Patch Type
10.2.5 Canada Transdermal Patches Market by Application
10.3 Mexico Transdermal Patches Market
10.3.1 Mexico Transdermal Patches Market by End User
10.3.2 Mexico Transdermal Patches Market by Distribution Channel
10.3.3 Mexico Transdermal Patches Market by Adhesive Type
10.3.4 Mexico Transdermal Patches Market by Patch Type
10.3.5 Mexico Transdermal Patches Market by Application
10.4 Rest of North America Transdermal Patches Market
10.4.1 Rest of North America Transdermal Patches Market by End User
10.4.2 Rest of North America Transdermal Patches Market by Distribution Channel
10.4.3 Rest of North America Transdermal Patches Market by Adhesive Type
10.4.4 Rest of North America Transdermal Patches Market by Patch Type
10.4.5 Rest of North America Transdermal Patches Market by Application
Chapter 11. Company Profiles
11.1 Johnson & Johnson
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Segmental and Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 SWOT Analysis
11.2 Viatris, Inc. (Mylan N.V.)
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Segmental Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Partnerships, Collaborations, and Agreements:
11.2.6 SWOT Analysis
11.3 Boehringer Ingelheim International GmbH
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Regional & Segmental Analysis
11.3.4 Research & Development Expenses
11.3.5 SWOT Analysis
11.4 Endo International PLC
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Segmental Analysis
11.4.4 Research & Development Expense
11.4.5 SWOT Analysis
11.5 Bayer AG
11.5.1 Company Overview
11.5.2 Financial Analysis
11.5.3 Segmental and Regional Analysis
11.5.4 Research & Development Expense
11.5.5 SWOT Analysis
11.6 Nitto Denko Corporation
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Segmental Analysis
11.6.4 Research & Development Expense
11.6.5 SWOT Analysis
11.7 Cipla Limited
11.7.1 Company Overview
11.7.2 Financial Analysis
11.7.3 Segmental and Regional Analysis
11.7.4 Research & Development Expense
11.7.5 Recent strategies and developments:
11.7.5.1 Acquisition and Mergers:
11.7.6 SWOT Analysis
11.8 Amneal Pharmaceuticals, Inc.
11.8.1 Company Overview
11.8.2 Financial Analysis
11.8.3 Segmental Analysis
11.8.4 Research & Development Expenses
11.8.5 Recent strategies and developments:
11.8.5.1 Product Launches and Product Expansions:
11.8.6 SWOT Analysis
11.9 Novartis AG
11.9.1 Company Overview
11.9.2 Financial Analysis
11.9.3 Segmental and Regional Analysis
11.9.4 Research & Development Expense
11.9.5 SWOT Analysis
11.10. AbbVie, Inc.
11.10.1 Company Overview
11.10.2 Financial Analysis
11.10.3 Regional Analysis
11.10.4 Research & Development Expense
11.10.5 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings